RADIATION INDUCED SIGNAL TRANSDUCTION & GENE EXPRESSION
Project Number5R29GM048229-03
Contact PI/Project LeaderMILLER, STEVEN C
Awardee OrganizationSRI INTERNATIONAL
Description
Abstract Text
Radiation exposure results in direct and indirect damage to many
different molecules in cells, and radiation-induced DNA damage is
believed to be the cause of cell death. Mammalian cells respond
to radiation-induced DNA damage through specific, inducible
pathways that are regulated through poorly understood mechanisms
that result in the activation and expression of specific genes.
Some effects of radiation are mediated through signaling pathways
composed of sequence-specific DNA binding proteins that are
involved in the regulation of responsive genes. In our preliminary
studies we have investigated the role of the inducible
transcription factor NF-(kappa)B in mediating the expression of a
reporter gene directed by a promoter that is induced by radiation
damage: the HIV1 LTR. The objective of this proposal is to further
define the role of reactive oxygen intermediates (ROIs), DNA
damage, and NF-(kappa)B DNA binding in the regulation of
radiation-induced gene expression.
We have demonstrated that UV irradiation of mouse L cells activated
NF-(kappa)B DNA binding and reporter gene expression. In contrast,
treatment with ionizing radiation failed to activate reporter gene
expression.' Agents such as tumor necrosis factor (TNF) and phorbol
ester (PMA), which generate ROIs, activated NF-(kappa)B DNA binding
without altering reporter gene expression, suggesting that
NF-(kappa)B was required but was not sufficient to activate gene
expression in this cell line. A strategy of using cell fusion to
construct heterokaryons was devised to functionally test for the
presence of additional factors. Heterokaryons formed by fusing
UV-irradiated human cells with mouse L cells containing an
integrated HIV1 LTR-directed lacZ gene directly demonstrated that
UV irradiation activated a trans-acting pathway that can pass from
a UV-irradiated nucleus and act on a target gene in a noniiradiated
nucleus. DNA damage or distortion in the DNA conformation around
the inducible gene is unlikely to be involved, because the reporter
gene was never exposed to UV irradiation.
This system will be used to directly test the role of UV- and
ionizing radiation-damaged DNA in the signaling pathway in the
absence of exposing cells to radiation. To further explore the
relationship between NF-(kappa)B-mediated gene regulation and the
response to ionizing radiation, we have characterized a human cell
line that is strongly induced by agents that generate ROIs.
Microcell-mediated human chromosome transfer will be used to
evaluate the existence of human factors that complement the defect
in gene expression in mouse L cells. The information derived from
this investigation will increase our understanding of cellular
mechanisms involved in radiation-induced gene expression.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA binding proteinDNA damagebiological signal transductioncell fusionclone cellselectroporationflow cytometryfluorescence microscopyfree radical oxygengene expressiongenetic regulationgenetic transcriptionheterokaryonhuman genetic material tagin situ hybridizationionizing radiationradiation dosageradiation resistancetransfectionultraviolet radiation
No Sub Projects information available for 5R29GM048229-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R29GM048229-03
Patents
No Patents information available for 5R29GM048229-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R29GM048229-03
Clinical Studies
No Clinical Studies information available for 5R29GM048229-03
News and More
Related News Releases
No news release information available for 5R29GM048229-03
History
No Historical information available for 5R29GM048229-03
Similar Projects
No Similar Projects information available for 5R29GM048229-03